Mass Board Exodus at 23andMe Leaves Company With Tough Decisions Ahead

Posted
Months after 23andMe CEO Anne Wojcicki publicly stated she wants to take the company she co-founded private, all of the company’s independent board directors have resigned. The board letter to Wojcicki stated that its members preferred resigning over continuing to have a difference of view over the direction of the company. The post Mass Board Exodus at 23andMe Leaves Company With Tough Decisions Ahead appeared first on MedCity News.

Continue reading at MedCity News »

BioPharma, Daily, Diagnostics, 23andMe, biopharma nl, corporate governance, genetic testing